Amryt Pharma plc (AMYT) Stock Analysis
DELISTED 2025
What happened to Amryt Pharma plc (AMYT) stock?
Amryt Pharma plc (AMYT) no longer trades on public markets. It was delisted in January 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2025
- Last recorded price (historical):
- $14.70 (last quote on record before the January 2025 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Amryt Pharma plc (AMYT). Amryt Pharma plc is a biopharmaceutical company focused on developing and commercializing treatments for rare and orphan diseases. The company's portfolio includes therapies for conditions like lipodystrophy, acromegaly, and Homozygous familial Hypercholesterolaemia.
Last analyzed: Mar 16, 2026Amryt Pharma plc (AMYT) Healthcare & Pipeline Overview
Amryt Pharma plc ADR Information Sponsored
Amryt Pharma plc (AMYT) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 2
- ADR Ratio: 1:1
More about this archive record
Can I still buy AMYT shares?
No. AMYT stopped trading on public markets in January 2025, so the shares are not available through a broker. Anything you see quoted for AMYT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AMYT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Amryt Pharma plc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.